TG Therapeutics
Stock Forecast, Prediction & Price Target
TG Therapeutics Financial Estimates
TG Therapeutics Revenue Estimates
TG Therapeutics EBITDA Estimates
TG Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $6.68M N/A | $2.78M -58.36% | $233.66M 8290.01% | Avg: $472.36M Low: $472.36M High: $472.36M avg. 102.15% | Avg: $616.66M Low: $616.66M High: $616.66M avg. 30.54% | Avg: $837.18M Low: $837.18M High: $837.18M avg. 35.76% | Avg: $1.05B Low: $1.05B High: $1.05B avg. 26.16% |
Net Income
% change YoY
| $-355.55M N/A | $-203.83M 42.67% | $12.67M 106.21% | Avg: $88.91M Low: $88.91M High: $88.91M avg. 601.70% | Avg: $153.26M Low: $153.26M High: $153.26M avg. 72.35% | Avg: $377.21M Low: $377.21M High: $377.21M avg. 146.12% | Avg: $513.83M Low: $513.83M High: $513.83M avg. 36.22% |
EBITDA
% change YoY
| $-342.46M N/A | $-188.14M 45.06% | $26.1M 113.87% | Avg: $-369.37M Low: $-369.37M High: $-369.37M avg. -1515.23% | Avg: $-482.21M Low: $-482.21M High: $-482.21M avg. -30.54% | Avg: $-654.66M Low: $-654.66M High: $-654.66M avg. -35.76% | Avg: $-825.97M Low: $-825.97M High: $-825.97M avg. -26.16% |
EPS
% change YoY
| -$2.69 N/A | -$1.51 43.86% | $0.09 105.91% | Avg: $0.6 Low: $0.6 High: $0.6 avg. 570.49% | Avg: $1.03 Low: $1.03 High: $1.03 avg. 72.35% | Avg: $2.54 Low: $2.54 High: $2.54 avg. 146.12% | Avg: $3.46 Low: $3.46 High: $3.46 avg. 36.22% |
Operating Expenses
% change YoY
| $350.66M N/A | $195.35M -44.28% | $198.89M 1.81% | Avg: $93.68B Low: $93.68B High: $93.68B avg. 47000.96% | Avg: $122.30B Low: $122.30B High: $122.30B avg. 30.54% | Avg: $166.03B Low: $166.03B High: $166.03B avg. 35.76% | Avg: $209.48B Low: $209.48B High: $209.48B avg. 26.16% |
FAQ
What is TG Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 214.10% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 88.91M, average is 88.91M and high is 88.91M.
What is TG Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 48.65% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $472.36M, average is $472.36M and high is $472.36M.
What is TG Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 206.29% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $0.6, average is $0.6 and high is $0.59.